UNSPSC 51411605: Glyceryl trinitrate or glyceryltrinitrate or nitroglycerin

This classification denotes a vasodilating agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G59M7S0WS3. European Medicines Agency schedules Glonoinum in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB49804. Nitroglycerin generally arises in the molecular formula C3H5N3O9. The term 'nitroglycerin' is a United States Homeopathic Pharmacopoeia Name designation. SMILES: O([N](=O)O)C(CO[N](=O)O)CO[N](=O)O.

UNSPSC 51411605 Glyceryl trinitrate or glyceryltrinitrate or nitroglycerin is a Commodity code covering pharmaceutical-grade emergency and critical-care medications supplied to state and local health, public safety, and pharmacy benefit programs. State and local governments buy this product through direct vendor contracts with fire rescue departments, emergency medical services, state health agencies, and cooperative purchasing alliances that supply pharmaceutical products to multiple member jurisdictions. Recent solicitations show municipalities and state agencies acquiring this medication in units ranging from hundreds to thousands of doses, with firm pricing, nine-month-plus expiration windows, and rapid delivery (within ten calendar days) as standard contract requirements. Purchasing bodies include city fire departments, state pharmacy benefit programs, and multistate cooperative purchasing groups. The market includes small and local business enterprise set-asides and compliance requirements for cGMP certification, FDA registration, OSHA Hazard Communication Standards documentation, and accessibility reporting under WCAG 2.2 standards.

Activity spans multiple states and cooperative purchasing vehicles. The City of Tampa Fire Rescue issued IFB 26P00188 in April 2026 for Advanced Life Support Medications including this product, with a $40,000 estimated value, a small local business enterprise sheltered market designation with 5 percent bid discount, and award within 120 days to the lowest responsive bidder. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued RFP S1070000015802 in January 2026 for generic multi-source pharmaceuticals and OTC products with response due March 26, 2026 and contract effectiveness July 1, 2026, requiring distribution through three authorized wholesalers (AmerisourceBergen/Cencora, Cardinal Health, Morris & Dickson) and serving participating state and local facilities in Minnesota and Oregon. The Texas Health and Human Services Commission issued RFI HHS0017013 in April 2026 to gather vendor capabilities for a direct-to-manufacturer pharmacy initiative, signaling exploratory procurement activity that may lead to formal RFP release. The code sees active procurement across municipal fire departments, state health agencies, and multistate cooperative purchasing consortia.